Biotech stock Alkermes plunges 20% after FDA refuses to review its depression treatment

Posted in IT

  Richard Pops, chairman and chief executive officer of Alkermes Shares of biotech company Alkermes dropped 20 percent Monday after announcing the U.S. Food and Drug Administration refused to review the firm’s drug for treating depression. The stock tumbled 20 percent to around $46.25 a share in morning trading. As of Thursday’s close, Alkermes was up 5.9….

Biotech stock Alkermes plunges 20% after FDA refuses to review its depression treatment
The 12 Best Ways to Make Extra Money in 2018

The 12 Best Ways to Make Extra Money in 2018

DISCLOSURE: Some of the links in this post are from our sponsors. We’re letting you know because it’s what Honest Abe would do. After all, he is on our favorite coin New year, new you, right? Cliche as it may sound, it’s never a bad time to start padding your bank account, regardless of what time of….

BOOK REVIEW: Keep your job and hustle your way to an extra income

Posted in Economics

Side Hustle: Build a side business and make extra money – without quitting your day job, by Chris Guillebeau ARE you one of those people who needs to earn more? Are you worried about jeopardising what you have for something that looks better, that may not be better? After all, you like your colleagues, the….

BOOK REVIEW: Keep your job and hustle your way to an extra income
Gordhan plans sweeping changes for SOEs as SARS suspends Moyane

Gordhan plans sweeping changes for SOEs as SARS suspends Moyane

Posted in EconomicsTagged

Johannesburg – Extensive changes are in the offing at the troubled state-owned companies as new Public Enterprises Minister Pravin Gordhan moves to tackle their many management and financial failings. Power utility Eskom Holdings and several other state entities have been caught up in graft and management scandals over recent years and repeatedly called on the….

Stock market falls on Facebook, rate hike and trade war worries

Posted in EconomicsTagged ,

Investors apparently don’t like the data privacy controversy engulfing Facebook, and that worry — along with rate hike and trade war fears — pushed the stock market sharply lower Monday. Facebook has come under fire after a political intelligence firm accessed the profiles of more than 50 million users without their permission, an episode that raised questions over privacy and why Facebook didn’t alert users. Investors….

Stock market falls on Facebook, rate hike and trade war worries